ATTENTION!! Recent changes to the NIH appendix policy immediately affect your grant submissions.

The NIH appendix policy eliminates most items that investigators previously included in the application appendix. For current and future grant submissions please be sure that application appendices are consistent with the items identified in NOT-OD-16-129 (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-129.html). Applications will be withdrawn and not reviewed if they are submitted with inappropriate appendix materials.

In short, the only allowable appendix materials are:

For applications proposing clinical trials (unless the FOA provides other instructions for these materials):
• Clinical trial protocols
• Investigator’s brochure from Investigational New Drug (IND), as appropriate

For all applications:
• Blank informed consent/assent form;
• Blank surveys, questionnaires, data collection instruments;
• FOA-specified items. (NOTE: If appendix materials are required in the FOA, review criteria for that FOA will address those materials, and applications submitted without those appendix materials will be considered incomplete and will not be reviewed.)

CONNECT

PRIDE Coordination Core
Washington University in St. Louis
Division of Biostatistics
660 South Euclid Avenue, Box 8067
St. Louis, MO 63110

Email: PRIDECC@wubios.wustl.edu



web
analytics


LEARN

APPLY

SUPPORT

Initiated and Funded by grant from the
National Heart Lung and Blood Institute (NHLBI)


NETWORKING
Join us on
LinkedIn
LinkedIn
Facebook
Facebook

© 2010 PRIDE Coordination Core Suffusion WordPress theme by Sayontan Sinha